EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, ABP: Abpro Holdings Inc

11 Nov 25 15:59
LAST:

5.990

CHANGE:
 0.16		OPEN:
5.790		HIGH:
6.000		ASK:
0.000		VOLUME:
8.9K
CHG(%):
2.75		PREV:
5.820		LOW:
5.590		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
11 Nov 255.7906.0005.5905.98012.0K
10 Nov 255.6505.9605.4705.82029.9K
07 Nov 255.5705.7705.2515.62067.5K
06 Nov 255.5005.6605.3605.61539.4K
05 Nov 255.5105.7305.1005.55096.9K
04 Nov 256.2606.4805.2705.3303.22M
03 Nov 255.0305.5004.6305.270222.9K
31 Oct 250.1910.1910.1800.1822.68M
30 Oct 250.1990.2000.1910.1961.17M
29 Oct 250.2000.2060.1990.2011.42M

COMPANY PROFILE

Name:Abpro Holdings Inc
About:Abpro Holdings, Inc., a biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology. Its platforms include DiversImmune, a discovery platform that generates a diverse collection of proprietary antibodies against clinically validated and novel targets; and MultiMab, an engineering platform that provides the flexibility to combine antibody building blocks in different combinations and orientations to create fit for purpose novel full-length multi-specific antibody constructs. The company's lead product candidates include ABP-102, a next generation immuno-oncology TetraBi antibody targeting HER2 and CD3 is developed for the treatment of HER2+ solid tumors, including breast and gastric cancers; and ABP-201, a TetraBi antibody format that simultaneously inhibit VEGF and ANG-2 for the treatment of vascular diseases of the eye, including diabetic macular edema and wet age-related macular degeneration. It also develops ABP-110, a TetraBi antibody targeting GPC3 and CD3 for the treatment of hepatocellular carcinoma; and ABP-150, a TetraBi antibody targeting claudin 18.2 and CD3 for the treatment of gastric cancers. The company has strategic partnership with Celltrion Inc. and Abpro Bio International, Inc. Abpro Holdings, Inc. was incorporated in 2004 and is headquartered in Woburn, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:68 Cummings Park Drive, Woburn, MA, United States, 01801
Website:https://abpro.co
CIK:0001670356
ISIN:US0008471031
FIGI:BBG013X0S7F3

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-7.12 
Forward P/E:-22.91 
Price to Sales:79.82 
Price to Book:-17.89 
Operating Margin:-54.21 
Return on Assets:-1.89 
Return on Equity:1.16 
EPS Ratio:-0.34 
Revenue:183.0K 
Shares:80.17M 
Market Cap:480.2M 

TECHNICAL INDICATORS

MA5:5.724.8%
MA10:3.9850.6%
MA20:2.09186.7%
MA50:0.96524.0%
MA100:0.60899.7%
MA200:0.521,056.8%
STO9:92.06 
STO14:92.06 
RSI14:99.44 
MTM14:5.78
ROC14:28.89 
ATR:0.64 
Week High:6.488.2%
Week Low:5.1017.5%
Month High:6.488.2%
Month Low:0.171,056.8%
Volatility:20.49 

RECENT SPLITS

Date Ratio
03 Nov 20251-30